Market Cap (In SEK)
82.53 Million
Revenue (In SEK)
-
Net Income (In SEK)
-27.03 Million
Avg. Volume
99.96 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.27-1.14
- PE
- -
- EPS
- -
- Beta Value
- 0.114
- ISIN
- SE0016013460
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Tine Kold Olesen Ph.D.
- Employee Count
- -
- Website
- https://biosergen.net
- Ipo Date
- 2021-06-24
- Details
- Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.
More Stocks
-
3073DD Holdings Co.,Ltd.
3073
-
ANZLYAir New Zealand Limited
ANZLY
-
EBO
-
MHLD
-
AHX
-
600845
-
NIVF
-
WWLWawel S.A.
WWL